Acromegaly References

Last updated: 20 September 2024
  1. Ben-Shlomo A, Melmed S. Acromegaly. Endocrinol Metab Clin North Am. 2008 Mar;37(1):101-122. PMID: 18226732
  2. Bates B. New acromegaly guidelines target premature, mortality, morbidity. Elsevier Global Medical News. 2009 Feb
  3. Keith E. Acromegaly: a new therapy. Cancer Control. 2002 May;9(3):232-235
  4. Katznelson L, Atkinson JL, Cook DM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly - 2011 update. Endocr Pract. 2011 Jul;17(4):1-44. www.aace.com. https://www.aace.com/. PMID: 21846619
  5. Lamberts SW. Acromegaly and its treatment. J Endocrinol. 1997 Oct;155(Suppl 1):S49-S51. PMID: 9389995
  6. Giustina A, Barkan A, Casanueva FF, et al. Criteria for the cure of acromegaly: a consensus statement. J Clin Endocrinol Metab. 2000 Feb;85(2):526-529. PMID: 10690849
  7. Melmed C, Casanueva FF, Cavagnini F, et al; Acromegaly Treatment Consensus Workshop Participants. Consensus: guidelines for acromegaly management. J Clin Endocrinol Metab. 2002 Sep;87(9):4054-4058. PMID: 12213843
  8. Liuzzi A, Oppizzi G. Evidence of ocreotide subcutaneously in the treatment of acromegaly. J Endocrinol. 1997 Oct;155(Suppl 1):S61-S65. PMID: 9389999
  9. Melmed S, Colao A, Barkan A, et al. Guidelines for acromegaly management: an update. J Clin Endocrinol Metab. 2009 May;94(5):1509-1517. PMID: 19208732
  10. Stewart PM. Current therapy for acromegaly. Trends Endocrinol Metab. 2000 May;11(4):128-132. PMID: 10754533
  11. Patel YC, Ezzat S, Chik CL, et al. Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective. Clin Invest Med. 2000 Jun;23(3):172-187. PMID: 10911548
  12. Trainer PJ, Drake WM, Katznelson L, et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med. 2000 Apr;342(16):1171-1177. PMID: 10770982
  13. Zaloga GP, Marik P. AACE medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocr Pract. 2004 May;10(3):213-225. PMID: 15382339
  14. MedWormhttp://www.medworm.com/rss/index.php/Endocrinology/15/http://www.medworm.com/rss/medicalfeeds/specialities/Endocrinology.xml
  15. Khabdwala HM. Acromegaly. eMedicine. http://emedicine.medscape.com. May 2005.
  16. Melmed S. Treatment of acromegaly. UpToDate. https://www.uptodate.com. 2001.
  17. Shim M. Gigantism and acromegaly. eMedicine. http://emedicine.medscape.com/. Mar 2002.
  18. The Endocrine Society. Clinical control, anti-tumor and anti-proliferative effects with somatostatin analogues. Medscape. http://www.medscape.org/. 2002.
  19. Melmen S, Katznelson L. Treatment of acromegaly. UpToDate. https://www.uptodate.com/. 28 Apr 2023. Accessed 20 Feb 2024.
  20. Melmen S, Katznelson L. Diagnosis of acromegaly. UpToDate. https://www.uptodate.com/. 03 Dec 2021.
  21. Giustina A, Biermasz N, Casanueva FF, et al. Consensus on criteria for acromegaly diagnosis and remission. Pituitary. 2024 Feb;27(1):7-22. doi: 10.1007/s11102-023-01360-1. PMID: 37923946
  22. Ogedegbe OJ, Cheema AY, Khan MA, et al.. A comprehensive review of four clinical practice guidelines of acromegaly. Cureus. 2022 Sep;14(9):e28722. doi: 10.7759/cureus.28722. PMID: 36105896
  23. Shlomo M, Katznelson L. Diagnosis of acromegaly. UpToDate. https://www.uptodate.com. 26 Aug 2019. Accessed 21 Jan 2021.
  24. Shlomo M, Katznelson L. Causes and clinical manifestations of acromegaly. UpToDate. https://www.uptodate.com. 29 May 2020.
  25. Hussein Z, Bidin ML, Alias A. et al. Malaysian consensus statement for the diagnosis and management of acromegaly. J ASEAN Fed Endocr Soc. 2019;34(1):8-14. doi: 10.15605/jafes.034.01.03. PMID: 33442131
  26. Giustina A, Barkhoudarian G, Beckers A. et al. Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord. 2020 Dec;21(4):667-678. doi: 10.1007/s11154-020-09588-z. Accessed 15 Jan 2021. PMID: 32914330
  27. Fleseriu M, Biller BMK, Freda PU. et al. A Pituitary Society update to acromegaly management guidelines. Pituitary. 2020 Oct. doi: 10.1007/s11102-020-01091-7. PMID: 33079318
  28. Lugo G, Pena L, Cordido F. Clinical manifestations and diagnosis of acromegaly. Int J Endocrinol. 2012;2012:540398. doi: 10.1155/2012/540398. PMID: 22518126
  29. Zahr R, Fleseriu M. Updates in diagnosis and treatment of acromegaly. Eur Endocrinol. 2018 Sep;14(2):57-61. doi: 10.17925/EE.2018.14.2.57. PMID: 30349595
  30. Melmed S, Bronstein MD, Chanson P, et al. A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol. 2018 Sep;14(9):552-561. doi: 1038/s41574-018-0058-5. PMID: 30050156
  31. Melmed S. Diagnosis of acromegaly. UpToDate. www.uptodate.com. Aug 2015. Accessed 27 Jul 2017.
  32. Melmed S. Causes and clinical manifestations of acromegaly. UpToDate. www.uptodate.com. Oct 2015. Accessed 7 Aug 2017.
  33. Chanson P, Salenave S, Kamenicky P, et al. Pituitary tumors: acromegaly. Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):555-574. doi: 10.1016/j.beem.2009.05.010. Accessed 27 Jul 2017. PMID: 19945023
  34. Katznelson L, Laws ER Jr, Melmed S, et al. Acromegaly: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014 Nov;99(11):3933-3951. doi: 10.1210/jc.2014-2700. Accessed 29 Sep 2016. PMID: 25356808
  35. Melmed S, Jameson JL. Disorders of the anterior pituitary and hypothalamus. In: Jameson JL. Harrison’s Endocrinology. 2nd ed. New York: McGraw-Hill; 2010:16-49.
  36. AACE Acromegaly Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocrine Pract. 2004 May;10(3):213-225.
  37. MedWorm - Acromegalyhttp://www.medworm.com/rss/medicalfeeds/conditions/Acromegaly-News.xml
  38. MedWormhttp://www.medworm.com/rss/search.php?qu=acromegaly+gigantism&kid=3&t=Acromegaly&f=c&r=Any&news=1http://www.medworm.com/rss/medicalfeeds/conditions/Acromegaly-News.xml